A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, Keiji, Imai, Yumiko, Rao, Shuan, Gao, Hong, Guo, Feng, Guan, Bin, Huan, Yi, Yang, Peng +16 more·2005·Nature Medicine
DOI 10.1038/nm1267

Cited by (1,008)

Items 401–500 of 1,008

  1. ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism
    Jun Wang, Shanmeizi Zhao, Ming Liu, Zhiyao Zhao, Yiping Xu, Ping Wang, Meng Lin, Yanhui Xu, Bing Huang, Xiaoyu Zuo et al. · 2020 · medRxiv
  2. MicroRNome Analysis Unravels the Molecular Basis of SARS Infection in Bronchoalveolar Stem Cells
    Bibekanand Mallick, Zhumur Ghosh, Jayprokas Chakrabarti · 2009 · PLoS ONE
  3. Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63 Determine Recognition of Their Respective Cellular Receptors
    Heike Hofmann, Graham Simmons, Andrew J. Rennekamp, Chawaree Chaipan, Thomas Gramberg, Elke Heck, Martina Geier, Anja Wegele, Andrea Marzi, Paul F. Bates et al. · 2006 · Journal of Virology
  4. A hypothesized role for dysregulated bradykinin signaling in COVID‐19 respiratory complications
    Joseph A. Roche, Renuka Roche · 2020 · The FASEB Journal
  5. Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19
    Cheng, Jinyu, Zhang, Ji, Wu, Zhongdao, Sun, Xiaoqiang · 2021 · Briefings in Bioinformatics
  6. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
    Parastoo Tarighi, Samane Eftekhari, Milad Chizari, Mahsa Sabernavaei, Davod Jafari, Parastoo Mirzabeigi · 2021 · European Journal of Pharmacology
  7. Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells
    Anna de Lang, Albert D. M. E. Osterhaus, Bart L. Haagmans · 2006 · Virology
  8. The flexibility of ACE2 in the context of SARS-CoV-2 infection
    Emilia Pecora de Barros, Lorenzo Casalino, Zied Gaieb, Abigail C. Dommer, Yuzhang Wang, Lucy Fallon, Lauren E. Raguette, Kellon A. A. Belfon, Carlos L. Simmerling, Rommie E. Amaro · 2020 · Biophysical Journal
  9. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain
    Amelia J. McFarland, Muhammad Saad Yousuf, Stephanie I. Shiers, Theodore John Price · 2021 · PAIN Reports
  10. Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola
    David S. Fedson · 2016 · Annals of Translational Medicine
  11. miRNA-200c-3p is crucial in acute respiratory distress syndrome
    Qiang Liu, Jianchao Du, Xuezhong Yu, Jun Xu, Fengming Huang, Xiaoyun Li, Cong Zhang, Xiao Li, Jiahui Chang, Daozhen Shang et al. · 2017 · Cell Discovery
  12. Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
    Sabyasachi Senapati, Pratibha Banerjee, Sandilya Bhagavatula, Prem Prakash Kushwaha, Shashank Kumar · 2021 · Journal of Genetics
  13. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID‐19—Mechanisms and Therapeutic Targets
    Adriana Fodor, Brînduşa Tiperciuc, Cezar Login, Olga Hilda Orasan, Andrada-Luciana Lazăr, Cristina Buchman, Patricia Hanghicel, Adela Sitar-Tăut, Ramona Suharoschi, Romana Vulturar et al. · 2021 · Oxidative Medicine and Cellular Longevity
  14. Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion
    Graham Simmons, Stephanie Bertram, Ilona Glowacka, Imke Steffen, Chawaree Chaipan, Juliet Agudelo, Kai Lü, Andrew J. Rennekamp, Heike Hofmann, Paul F. Bates et al. · 2011 · Virology
  15. Recently Discovered Human Coronaviruses
    Brigitte A. Wevers, Lia van der Hoek · 2009 · Clinics in Laboratory Medicine
  16. Acute lung injury in patients with COVID‐19 infection
    Liyang Li, Qihong Huang, Diane C. Wang, David H. Ingbar, Xiangdong Wang · 2020 · Clinical and Translational Medicine
  17. Statins: Could an old friend help in the fight against COVID‐19?
    Raúl R. Rodrigues-Díez, Antonio Tejera‐Muñoz, Laura Márquez‐Expósito, Sandra Rayego‐Mateos, Laura Santos‐Sanchez, Vanessa A Marchant, Lucía Tejedor-Santamaria, Adrian Mario Ramos, Alberto Ortíz, Jesús Egido et al. · 2020 · British Journal of Pharmacology
  18. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
    Rainer W. J. Kaiser, Alexander Leunig, Kami Pekayvaz, Oliver Popp, Markus Joppich, Vivien Polewka, Raphael Escaig, Afra Anjum, Marie‐Louise Hoffknecht, Christoph Gold et al. · 2021 · JCI Insight
  19. Pyroptosis-Induced Inflammation and Tissue Damage
    Yinan Wei, Ling Yang, Ankit Pandeya, Jian Cui, Yan Zhang, Zhenyu Li · 2021 · Journal of Molecular Biology
  20. Salivary glands are a target for SARS‐CoV‐2: a source for saliva contamination
    Bruno Fernandes Matuck, Marisa Dolhnikoff, Amaro Nunes Duarte‐Neto, Gilvan Maia, Sara Costa Gomes, Daniel Isaac Sendyk, Amanda Zarpellon, Nathália Paiva de Andrade, Renata Aparecida de Almeida Monteiro, João Renato Rebello Pinho et al. · 2021 · The Journal of Pathology
  21. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
    Mari Terada, Hiroshi Ohtsu, Sho Saito, Kayoko Hayakawa, Shinya Tsuzuki, Yusuke Asai, Nobuaki Matsunaga, Satoshi Kutsuna, Wataru Sugiura, Norio Ohmagari · 2021 · BMJ Open
  22. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
    Rudra P. Saha, Ashish Ranjan Sharma, Manoj Kumar Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, Manojit Bhattacharya, Sang Soo Lee, Chiranjib Chakraborty · 2020 · Frontiers in Pharmacology
  23. Scavenger receptors in host defense: from functional aspects to mode of action
    Qamar Taban, Peerzada Tajamul Mumtaz, Khalid Zaffar Masoodi, Ehtishamul Haq, Syed Mudasir Ahmad · 2022 · Cell Communication and Signaling
  24. Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease
    Christine Wohlford-Lenane, David Kyle Meyerholz, Stanley M. Perlman, Haixia Zhou, Dat Tran, Michael E. Selsted, Paul B. McCray · 2009 · Journal of Virology
  25. SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
    Phoebe C M Williams, Annaleise R. Howard‐Jones, Peter S. Hsu, Pamela Palasanthiran, Paul Edgar Gray, Brendan Joseph McMullan, Philip N Britton, Adam William Bartlett · 2020 · Pathology
  26. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory
    Maurizio Carcaterra, Cristina Caruso · 2020 · Medical Hypotheses
  27. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells
    Ruben Manuel Luciano Colunga Biancatelli, Pavel A. Solopov, Elizabeth R. Sharlow, John Stephen Lazo, Paul Ellis Marik, John D. Catravas · 2021 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  28. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
    Yuwen Zhou, Yao Xie, Liansha Tang, Dan Pu, Yajuan Zhu, Jiyan Liu, Xuelei Ma · 2021 · Signal Transduction and Targeted Therapy
  29. Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice
    Emily J Grundy, Taiba Suddek, Filippos T Filippidis, Azeem Majeed, Sophie Coronini‐Cronberg · 2020 · Tobacco Induced Diseases
  30. Considerations for Heart Failure Care During the COVID-19 Pandemic
    Ersilia M. DeFilippis, Nosheen Reza, ELENA M. DONALD, Michael M. Givertz, JoAnn Lindenfeld, Mariell L Jessup · 2020 · JACC Heart Failure
  31. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis
    Kirill Gorshkov, Kimihiro Susumu, Jiji Chen, Miao Xu, Manisha Pradhan, Wei Zhu, Xin Hu, Joyce C. Breger, Mason A. Wolak, Eunkeu Oh · 2020 · ACS Nano
  32. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
    Jinghua Lu, Peter D. Sun · 2020 · Journal of Biological Chemistry
  33. Pathology of Experimental SARS Coronavirus Infection in Cats and Ferrets
    Judith M. A. van den Brand, Bart L. Haagmans, Lonneke M. E. Leijten, Debby A.J. van Riel, B. E. E. Martina, Albert D. M. E. Osterhaus, Thijs Kuiken · 2008 · Veterinary Pathology
  34. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
    Niraj Konchady Shenoy, Rebecca A. Luchtel, Perminder Gulani · 2020 · BMC Medicine
  35. Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients
    Yingxia Liu, Fengming Huang, Jun Xu, Penghui Yang, Yuhao Qin, Mengli Cao, Zhaoqin Wang, Xiaohe Li, Shaogeng Zhang, Lu Ye et al. · 2020 · medRxiv
  36. COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
    Rysz, Susanne, Al-Saadi, Jonathan, Sjöström, Anna, Farm, Maria, Campoccia Jalde, Francesca, Plattén, Michael, Eriksson, Helen, Klein, Margareta, Vargas-Paris, Roberto, Nyrén, Sven et al. · 2021 · Nature Communications
  37. Angiotensin-Converting Enzyme 2–Independent Action of Presumed Angiotensin-Converting Enzyme 2 Activators
    Philipp Konstantin Haber, Minghao Ye, Jan A Wysocki, Christoph Maier, Syed K. Haque, DANIEL C. BATLLE · 2014 · Hypertension
  38. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo. Informe del Registro COVID-19 de la Sociedad Española de Nefrología (SEN)
    José Emilio Sánchez-Álvarez, Miguel Pérez Fontán, Carlos Jiménez Martín, Miquel Blasco Pelícano, Carlos Jesús Cabezas-Reina, Ángel Sevillano, Edoardo Melilli, Marta Crespo, Manuel Macía Heras, María Dolores del Pino y Pino · 2020 · Nefrología
  39. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections
    Yu He, Jianhui Wang, Fang Li, Yuan Shi · 2020 · Frontiers in Microbiology
  40. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2
    Shima Shahbaz, Lai Xu, Mohammed S. Osman, Wendy Sligl, Justin A. Shields, Michael Joyce, D. Lorne Tyrrell, Olaide Oyegbami, Shokrollah Elahi · 2021 · Stem Cell Reports
  41. COVID-19: Therapeutics and Their Toxicities
    Michael A. Chary, Alexander F. Barbuto, Sudeh Izadmehr, Bryan D. Hayes, Michele M. Burns · 2020 · Journal of Medical Toxicology
  42. Coronavirus Disease 2019 (COVID‐19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease
    Tarek Alsaied, Jamil Aboulhosn, Timothy B. Cotts, Curt J. Daniels, Susan P. Etheridge, Timothy F. Feltes, Michelle Z. Gurvitz, Mark Lewin, Matthew E. Oster, Arwa S. Saidi · 2020 · Journal of the American Heart Association
  43. Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study
    Sun‐Young Jung, Jae Chol Choi, Seung‐Hun You, Won‐Young Kim · 2020 · Clinical Infectious Diseases
  44. Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course
    Rashika Bansal, Sriram Gubbi, Ranganath Muniyappa · 2020 · Endocrinology
  45. Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury
    G Rey-Parra, A. Vadivel, Lavinia Coltan, A. Hall, Farah Eaton, Manfred Schuster, Hans Loibner, Josef Martin Penninger, Zamaneh Kassiri, Gavin Y. Oudit et al. · 2012 · Journal of Molecular Medicine
  46. Severe COVID-19: A Review of Recent Progress With a Look Toward the Future
    Peng Xie, Wanyu Ma, Hongbo Tang, Daishun Liu · 2020 · Frontiers in Public Health
  47. Covid-19: the renin–angiotensin system imbalance hypothesis
    Katharina Lanza, Lucas Giandoni Perez, Larissa Braga Costa, Thiago Macedo e Cordeiro, Vitria A. Palmeira, Victor Teatini Ribeiro, Ana Cristina Simões e Silva · 2020 · Clinical Science
  48. Cancer and COVID-19: Unmasking their ties
    Alfredo Addeo, Alex Friedlaender · 2020 · Cancer Treatment Reviews
  49. Tackling the cytokine storm in COVID-19, challenges and hopes
    Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad, Hany A. Omar · 2020 · Life Sciences
  50. Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity
    Xiaocao Liu, Ruma Raghuvanshi, Fatma Duygu Ceylan, Bradley W. Bolling · 2020 · Journal of Agricultural and Food Chemistry
  51. ACE2 Elevation in Severe COVID-19
    Roman Reindl‐Schwaighofer, Sebastian Hödlmoser, Farsad Alexander Eskandary, Marko Poglitsch, Diana Bonderman, Robert Paul Straßl, Judith Helene Aberle, Rainer W. Oberbauer, Alexander Zoufaly, Manfred Hecking · 2021 · American Journal of Respiratory and Critical Care Medicine
  52. Lifestyle factors in the prevention of COVID-19
    Klaus W. Lange, Yukiko Nakamura · 2020 · Global Health Journal
  53. Assessing the utility of deep neural networks in predicting postoperative surgical complications: a retrospective study
    Alexander Bonde, Kartik M. Varadarajan, Nicholas Bonde, Anders Troelsen, Orhun Kamil Muratoglu, Henrik Malchau, Anthony D. Yang, Hasan Badre Alam, Martin Sillesen · 2021 · The Lancet Digital Health
  54. Hypoxic and Pharmacological Activation of HIF Inhibits SARS-CoV-2 Infection of Lung Epithelial Cells
    Peter A. C. Wing, Thomas P. Keeley, Xiaodong Zhuang, Young Seok Lee, Maria Prange‐Barczynska, Senko Tsukuda, Sophie B. Morgan, Adam C. Harding, Isobel L.A. Argles, Samvid Kurlekar et al. · 2020 · Cell Reports
  55. Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury
    Yuntao Wu · 2020 · Virologica Sinica
  56. Potential role of statins in COVID-19
    Ken Cheah Hooi Lee, Duu Wen Sewa, Ghee Chee Phua · 2020 · International Journal of Infectious Diseases
  57. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
    Elena Garreta, Patricia Prado, Megan Lynn Stanifer, Vanessa Monteil, Andrés Marco, Asier Ullate‐Agote, Daniel Moya‐Rull, Amaia Vilas‐Zornoza, Carolina Tarantino, Juan P. Romero et al. · 2022 · Cell Metabolism
  58. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?
    Andréa D. Fuzimoto, Ciro Isidoro · 2020 · Journal of Traditional and Complementary Medicine
  59. Advances in research on ACE2 as a receptor for 2019-nCoV
    Jie Wu, Wei Deng, Shumin Li, Xiuhong Yang · 2020 · Cellular and Molecular Life Sciences
  60. The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2
    Ryan Dz-Wei Chow, Medha Majety, Sidi Chen · 2021 · Nature Communications
  61. Vitamin D and Lung Outcomes in Elderly COVID-19 Patients
    Alberto Sulli, Emanuele Gotelli, Andrea Casabella, Sabrina Paolino, Carmen Pizzorni, Elisa Alessandri, Marco Grosso, Diego Ferone, Vanessa M. Smith, Maurizio Cutolo · 2021 · Nutrients
  62. Angiotensin‐converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS‐CoV‐2: A double‐edged sword?
    Yan, Tiantian, Xiao, Rong, Lin, Guoan · 2020 · The FASEB Journal
  63. Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets
    Benedikt Treml, Nikolaus Neu, Axel T. Kleinsasser, Christian Gritsch, Thomas Finsterwalder, Ralf Geiger, Manfred Schuster, Evelyne Janzek, Hans Loibner, Josef Martin Penninger et al. · 2010 · Critical Care Medicine
  64. Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation
    Matthew B. Frieman, Ralph Steven Baric · 2008 · Microbiology and Molecular Biology Reviews
  65. Covid-19, Coronavirus, SARS-CoV-2 and the small bowel
    Klaus M�nkemüller, Lucía C. Fry, Steffen Rickes · 2020 · Revista Española de Enfermedades Digestivas
  66. Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis
    Jarbas da Silva Motta, Anna Flavia Ribeiro dos Santos Miggiolaro, Seigo Nagashima, Caroline Busatta Vaz de Paula, Cristina Pellegrino Baena, Júlio Scharfstein, Lúcia de Noronha · 2020 · Frontiers in Immunology
  67. Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
    Wagner Gouvêa dos Santos · 2021 · Biomedicine & Pharmacotherapy
  68. Diabetes Epidemiology in the COVID-19 Pandemic
    Elizabeth Selvin, Stephen P. Juraschek · 2020 · Diabetes Care
  69. Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?
    Candida Joan Rebello, John P. Kirwan, Frank L. Greenway · 2020 · International Journal of Obesity
  70. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection
    Rosa, Bruce A., Ahmed, Mushtaq, Singh, Dhiraj K., Choreño-Parra, José Alberto, Cole, Journey, Jiménez-Álvarez, Luis Armando, Rodríguez-Reyna, Tatiana Sofía, Singh, Bindu, Gonzalez, Olga, Carrion, Ricardo et al. · 2021 · Communications Biology
  71. Smoking and COVID-19: Adding Fuel to the Flame
    Vivek Kumar Kashyap, Anupam Dhasmana, Andrew E. Massey, Sudhir Kotnala, Nadeem Zafar, Meena Jaggi, Murali Mohan Yallapu, Subhash C. Chauhan · 2020 · International Journal of Molecular Sciences
  72. Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study
    Javier Martínez‐Sanz, Alfonso Muriel, Raquel Ron, Sabina Herrera, José Antonio Pérez-Molina, Santiago Moreno, Sergio Serrano Villar · 2020 · Clinical Microbiology and Infection
  73. ACE2 and gut amino acid transport.
    S. Camargo, R. Vuille-Dit-Bille, Chantal F. Meier, F. Verrey · 2020 · Clinical science
  74. Molecular Biology of the SARS-Coronavirus
    Sunil Kumar Lal · 2010 · Springer eBooks
  75. Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients
    Begum Dariya, Ganji Purnachandra Nagaraju · 2020 · Cytokine & Growth Factor Reviews
  76. Molecular mechanisms of sex bias differences in COVID-19 mortality
    Yuchong Li, Mirjana Jerkić, Arthur S. Slutsky, Haibo Zhang · 2020 · Critical Care
  77. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2
    Stepan A. Nersisyan, M. Yu. Shkurnikov, Andrey A. Turchinovich, Evgeny N. Knyazev, Alexander Tonevitsky · 2020 · PLoS ONE
  78. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
    Andrew Higham, Alexander G. Mathioudakis, Jørgen Vestbo, Dave Singh · 2020 · European Respiratory Review
  79. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease
    HariOm Singh, Ranjana Hanumant Choudhari, Vijay Nema, Abdul Arif Khan · 2020 · Microbial Pathogenesis
  80. The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
    Tapan Behl, Ishnoor Kaur, SIMONA GABRIELA BUNGAU, Arun Kumar, Md. Sahab Uddin, Chanchal Kumar, Giridhari Pal, Sahil, Kamal Shrivastava, Gökhan Zengin et al. · 2020 · Life Sciences
  81. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection
    R. Pei, Jian-Qi Feng, Yecheng Zhang, Hao Sun, Lian Li, Xuejie Yang, Jiang-Ping He, Shuqi Xiao, Jin Xiong, Ying Lin et al. · 2020 · Protein & Cell
  82. SARS-CoV-2 Antiviral Therapy
    Kaiming Tao, Philip L. Tzou, Janin Nouhin, Hector Fabio Bonilla, Prasanna Jagannathan, Robert W. Shafer · 2021 · Clinical Microbiology Reviews
  83. A Dynamic Variation of Pulmonary ACE2 Is Required to Modulate Neutrophilic Inflammation in Response to Pseudomonas aeruginosa Lung Infection in Mice
    Chhinder Pal Sodhi, Jenny M. Nguyen, Yukihiro Yamaguchi, Adam D. Werts, Peng Lu, Mitchell R. Ladd, William B. Fulton, Mark L. Kovler, Sanxia Wang, Thomas Prindle et al. · 2019 · The Journal of Immunology
  84. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease
    Li Chen, Guang Hao · 2020 · Cardiovascular Research
  85. Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
    Calum T. Robb, Marie Goepp, Adriano Giorgio Rossi, Chengcan Yao · 2020 · British Journal of Pharmacology
  86. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
    Serena Del Turco, Annamaria Vianello, Rosetta Ragusa, Chiara Caselli, Giuseppina Basta · 2020 · Thrombosis Research
  87. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
    Federica Saponaro, Grazia Rutigliano, Simona Sestito, Lavinia Bandini, Barbara Storti, Ranieri Bizzarri, Riccardo Zucchi · 2020 · Frontiers in Molecular Biosciences
  88. Redox Role of ROS and Inflammation in Pulmonary Diseases
    Li Zuo, Denethi Wijegunawardana · 2021 · Advances in experimental medicine and biology
  89. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
    Ikram Omar Osman, Cléa Melenotte, Philippe Brouqui, Matthieu Million, Jean‐Christophe Lagier, Philippe Parola, Andréas Stein, Bernard La Scola, Line Meddeb, Jean‐Louis Mège et al. · 2021 · Frontiers in Immunology
  90. ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia
    Felice Rivellese, Edoardo Prediletto · 2020 · Autoimmunity Reviews
  91. First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations
    Alireza Paniri, Mohammad Mahdi Hosseini, Haleh Akhavan‐Niaki · 2020 · Journal of Biomolecular Structure and Dynamics
  92. Sex‐related differences in COVID‐19 lethality
    Claudia Renata Rezende Penna, Valentina Mercurio, Carlo Gabriele Tocchetti, Pasquale Pagliaro · 2020 · British Journal of Pharmacology
  93. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
    Tapan Behl, Ishnoor Kaur, Lotfi Aleya, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al‐Harrasi, SIMONA GABRIELA BUNGAU · 2021 · The Science of The Total Environment
  94. Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models*
    Satoshi Hagiwara, Hideo Iwasaka, Shigekiyo Matumoto, Seigo Hidaka, Takayuki Noguchi · 2009 · Critical Care Medicine
  95. Antihypertensive drugs and risk of COVID-19?
    Christopher James Tignanelli, Nicholas E. Ingraham, Matthew A. Sparks, Ronald A. Reilkoff, Tamara L Bezdicek, Bradley Benson, Timothy W. Schacker, Jeffrey G. Chipman, Michael A. Puskarich · 2020 · The Lancet Respiratory Medicine
  96. Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China
    Yiwu Zhou, Yanqi He, Huan Yang, Yu He, Ting Wang, Chen Zhu, Rong Yao, Zongan Liang · 2020 · PLoS ONE
  97. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
    Claudio Fenizia, Silvia Galbiati, Claudia Vanetti, Riccardo Vago, Mario Clerici, Carlo Tacchetti, Tiziana Daniele · 2021 · Cells
  98. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains
    Peter Radvák, Hyung‐Joon Kwon, Martina Košíková, Uriel Ortega‐Rodriguez, Ruoxuan Xiang, Je‐Nie Phue, Rong‐Fong Shen, James Rozzelle, Neeraj Kapoor, Taylor R. Rabara et al. · 2021 · Nature Communications
  99. Protein nanopore reveals the renin–angiotensin system crosstalk with single-amino-acid resolution
    Jie Jiang, Meng‐Yin Li, Xueyuan Wu, Yi‐Lun Ying, Huanxing Han, Yi‐Tao Long · 2023 · Nature Chemistry
  100. ACE2, a promising therapeutic target for pulmonary hypertension
    Vinayak Shenoy, Yanfei Qi, Michael J. Katovich, Mohan K. Raizada · 2011 · Current Opinion in Pharmacology